AR048899A1 - Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros - Google Patents
Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente purosInfo
- Publication number
- AR048899A1 AR048899A1 ARP050101958A ARP050101958A AR048899A1 AR 048899 A1 AR048899 A1 AR 048899A1 AR P050101958 A ARP050101958 A AR P050101958A AR P050101958 A ARP050101958 A AR P050101958A AR 048899 A1 AR048899 A1 AR 048899A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- inhalation
- alkoxy
- halogen
- powder formulations
- Prior art date
Links
- 239000000843 powder Substances 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente se refiere a formulaciones en polvo para la inhalacion, las cuales contienen b-agonistas enantioméricamente puros, y a procedimientos para su preparacion y a su uso como medicamentos, en especial como medicamentos para el tratamiento de enfermedades de las vías respiratorias. Reivindicacion 1: Polvos para inhalacion, que contienen uno o varios compuestos enantioméricamente puros de la formula general (1) en la que significan R1 es H, alquilo C1-4, alcoxi C1-4 o halogeno; R2 es H, alquilo C1-4, alcoxi C1-4 o halogeno; R3 es H, alquilo C1-4, alcoxi C1-4 o halogeno, OH, -O-alquilen C1-4-COOH u -O-alquilen C1-4-COO-alquilo C1-4; R4 es H, alquilo C1-4, alcoxi C1-4 o halogeno, eventualmente en forma de sus sales por adicion de ácidos farmacéuticamente tolerables, hidratos o solvatos, eventualmente en mezcla con uno o varios coadyuvantes fisiologicamente inocuos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004024451A DE102004024451A1 (de) | 2004-05-14 | 2004-05-14 | Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR048899A1 true AR048899A1 (es) | 2006-06-07 |
Family
ID=35058202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050101958A AR048899A1 (es) | 2004-05-14 | 2005-05-13 | Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1809236B1 (es) |
| JP (1) | JP4891899B2 (es) |
| KR (1) | KR101270449B1 (es) |
| CN (1) | CN1984638A (es) |
| AR (1) | AR048899A1 (es) |
| AU (1) | AU2005244424B2 (es) |
| BR (1) | BRPI0511136A (es) |
| CA (1) | CA2565915C (es) |
| DE (1) | DE102004024451A1 (es) |
| DK (1) | DK1809236T3 (es) |
| EA (1) | EA012582B1 (es) |
| ES (1) | ES2401786T3 (es) |
| IL (1) | IL179215A (es) |
| MX (1) | MXPA06013221A (es) |
| MY (1) | MY145838A (es) |
| NO (1) | NO20065078L (es) |
| PE (1) | PE20060239A1 (es) |
| PL (1) | PL1809236T3 (es) |
| SG (1) | SG152258A1 (es) |
| TW (1) | TW200607508A (es) |
| UA (1) | UA86807C2 (es) |
| UY (1) | UY28896A1 (es) |
| WO (1) | WO2005110359A1 (es) |
| ZA (1) | ZA200607785B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004024452A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation von Betaagonisten |
| KR20080036632A (ko) | 2005-08-08 | 2008-04-28 | 아젠터 디스커버리 리미티드 | 바이시클로[2.2.1]헵트-7-일아민 유도체 및 이들의 용도 |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| MX2008001976A (es) | 2005-08-15 | 2008-03-25 | Boehringer Ingelheim Int | Procedimiento para la preparacion de betamimeticos. |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| MX2011007036A (es) | 2008-12-30 | 2011-07-20 | Pulmagen Therapeutics Inflammation Ltd | Compuestos de sulfonamida para el tratamiento de trastornos respiratorios. |
| WO2010150014A1 (en) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| WO2011098746A1 (en) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| JP2015533131A (ja) | 2012-10-09 | 2015-11-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 咳を治療するためのベータ２−アドレナリン受容体作動薬 |
| WO2018108669A1 (en) | 2016-12-12 | 2018-06-21 | Boehringer Ingelheim International Gmbh | Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
| US4460581A (en) | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| NZ522677A (en) * | 2000-04-27 | 2004-10-29 | Boehringer Ingelheim Pharma | Novel, slow-acting betamimetics, a method for their production and their use as medicaments |
| GB0107106D0 (en) * | 2001-03-21 | 2001-05-09 | Boehringer Ingelheim Pharma | Powder inhaler formulations |
| DE10141377A1 (de) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Aufstreuverfahren zur Herstellung von Pulverformulierungen |
| DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| UA80123C2 (en) | 2002-04-09 | 2007-08-27 | Boehringer Ingelheim Pharma | Inhalation kit comprising inhalable powder of tiotropium |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
-
2004
- 2004-05-14 DE DE102004024451A patent/DE102004024451A1/de not_active Withdrawn
-
2005
- 2005-05-11 CA CA2565915A patent/CA2565915C/en not_active Expired - Fee Related
- 2005-05-11 MX MXPA06013221A patent/MXPA06013221A/es active IP Right Grant
- 2005-05-11 EA EA200602016A patent/EA012582B1/ru not_active IP Right Cessation
- 2005-05-11 SG SG200902738-4A patent/SG152258A1/en unknown
- 2005-05-11 BR BRPI0511136-6A patent/BRPI0511136A/pt not_active IP Right Cessation
- 2005-05-11 DK DK05747562.6T patent/DK1809236T3/da active
- 2005-05-11 ES ES05747562T patent/ES2401786T3/es not_active Expired - Lifetime
- 2005-05-11 KR KR1020067026352A patent/KR101270449B1/ko not_active Expired - Fee Related
- 2005-05-11 EP EP05747562A patent/EP1809236B1/de not_active Expired - Lifetime
- 2005-05-11 CN CNA2005800154329A patent/CN1984638A/zh active Pending
- 2005-05-11 UA UAA200612950A patent/UA86807C2/ru unknown
- 2005-05-11 AU AU2005244424A patent/AU2005244424B2/en not_active Ceased
- 2005-05-11 JP JP2007512080A patent/JP4891899B2/ja not_active Expired - Lifetime
- 2005-05-11 PL PL05747562T patent/PL1809236T3/pl unknown
- 2005-05-11 WO PCT/EP2005/005078 patent/WO2005110359A1/de not_active Ceased
- 2005-05-12 UY UY28896A patent/UY28896A1/es not_active Application Discontinuation
- 2005-05-12 PE PE2005000530A patent/PE20060239A1/es not_active Application Discontinuation
- 2005-05-12 MY MYPI20052155A patent/MY145838A/en unknown
- 2005-05-13 AR ARP050101958A patent/AR048899A1/es unknown
- 2005-05-13 TW TW094115490A patent/TW200607508A/zh unknown
-
2006
- 2006-09-18 ZA ZA200607785A patent/ZA200607785B/en unknown
- 2006-11-03 NO NO20065078A patent/NO20065078L/no not_active Application Discontinuation
- 2006-11-13 IL IL179215A patent/IL179215A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2401786T3 (es) | 2013-04-24 |
| AU2005244424B2 (en) | 2010-12-23 |
| EP1809236B1 (de) | 2012-12-26 |
| NO20065078L (no) | 2006-11-28 |
| CA2565915A1 (en) | 2005-11-24 |
| UY28896A1 (es) | 2005-12-30 |
| JP2007537195A (ja) | 2007-12-20 |
| PL1809236T3 (pl) | 2013-05-31 |
| DE102004024451A1 (de) | 2005-12-22 |
| MY145838A (en) | 2012-04-30 |
| PE20060239A1 (es) | 2006-03-27 |
| EP1809236A1 (de) | 2007-07-25 |
| DK1809236T3 (da) | 2013-02-11 |
| IL179215A (en) | 2011-04-28 |
| AU2005244424A1 (en) | 2005-11-24 |
| BRPI0511136A (pt) | 2007-11-27 |
| CN1984638A (zh) | 2007-06-20 |
| CA2565915C (en) | 2013-12-10 |
| EA200602016A1 (ru) | 2007-06-29 |
| UA86807C2 (ru) | 2009-05-25 |
| SG152258A1 (en) | 2009-05-29 |
| TW200607508A (en) | 2006-03-01 |
| WO2005110359A1 (de) | 2005-11-24 |
| KR20070016169A (ko) | 2007-02-07 |
| EA012582B1 (ru) | 2009-10-30 |
| ZA200607785B (en) | 2008-07-30 |
| MXPA06013221A (es) | 2007-02-08 |
| JP4891899B2 (ja) | 2012-03-07 |
| KR101270449B1 (ko) | 2013-06-04 |
| IL179215A0 (en) | 2007-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR048899A1 (es) | Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros | |
| AR041969A1 (es) | Medicamento para el tratamiento de la enfermedad pulmonar obstructiva cronica | |
| FI3578169T3 (fi) | Farmaseuttiset valmisteet, jotka käsittävät 4-{(1 r)-2-[(6-{2-[(2,6-diklooribentsyyli)oksi]etoksi}heksyyli)amino]-1-hydroksietyyli}-2-(hydroksimetyyli)fenolia | |
| MX391854B (es) | Formulaciones farmaceuticas que contienen hidrato de propilenglicol de dapagliflozina | |
| SV2007002359A (es) | Formas de dosificacion farmaceutica solidas administrables por via oral con liberacion modificada ref. bhco 41331/sv | |
| NI201200184A (es) | Morfolinopirimidinas y su uso en terapia | |
| GEAP201813485A (en) | Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof | |
| HN2008001666A (es) | Derivados acidos de cicloalquilamino | |
| AR055060A1 (es) | Derivados de n-(piridin-2-il)-sulfonamida | |
| ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| BRPI0611705A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de composto | |
| AR038686A1 (es) | Formulaciones de derivados de androstano y agonistas del adrenoreceptor beta 2 antiinflamatorios | |
| UY30440A1 (es) | Nuevos compuestos | |
| ECSP077402A (es) | Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica | |
| UA110463C2 (ru) | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНІЛ)-5Н-ПІРИМІДО[5,4-d][2]БЕНЗАЗЕПІН-2-ІЛ]АМІНО}-2-МЕТОКСИБЕНЗОЙНОЇ КИСЛОТИ ДЛЯ ЛІКУВАННЯ РАКУ Й ІНШИХ ЗАХВОРЮВАНЬ І ПОРУШЕНЬ СТАНУ ЗДОРОВ'Я | |
| AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
| UY31403A1 (es) | "derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos". | |
| BR112012013252A2 (pt) | composição farmacêutica tópica, preservativo, composto, e, uso do mesmo | |
| NZ593475A (en) | Calcium salts for reducing exhalation of infectious bioaerosol particles | |
| AR048718A1 (es) | Uso de formulaciones de meloxicam en medicina veterinaria | |
| FR2903107B1 (fr) | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
| MA32406B1 (fr) | Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens | |
| BR0311363A (pt) | Formulação farmacêutica de liberação imediata, uso da mesma, e, método para tratar um distúrbio cardiovascular em um paciente | |
| BRPI0610907A2 (pt) | composto ou precursores hidrolisÁveis in vivo ou sal farmaceuticamente aceitÁvel do mesmo, mÉtodos de tratamento ou profilaxia de uma doenÇa ou condiÇço na qual a modulaÇço do receptor de mch1 É benÉfica e de tratamento ou profilaxia de doenÇas, composiÇço farmacÊutica, e, uso de um composto | |
| UY29818A1 (es) | Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |